德展健康(000813.SZ)：WYY注射液脑卒中适应症IND申报相关实验基本完成，预计下半年提交临床试验申请

Group 1 - The core viewpoint of the article is that Dezhan Health (000813.SZ) has completed the basic experiments related to the IND application for WYY injection for stroke indications and plans to submit the clinical trial application in the second half of the year [1] Group 2 - The company is actively engaging with investors through an interactive platform to provide updates on its research and development progress [1] - The completion of the basic experiments indicates a significant step forward in the company's drug development pipeline [1] - The anticipated submission of the clinical trial application reflects the company's commitment to advancing its therapeutic offerings in the healthcare sector [1]